The estimated Net Worth of Christine Marie Mellon is at least $1.99 Milion dollars as of 9 June 2023. Ms Mellon owns over 7,951 units of Omnicell stock worth over $640,709 and over the last 4 years she sold OMCL stock worth over $581,536. In addition, she makes $768,277 as Exec. VP i Chief Admin. & People Officer at Omnicell.
Ms has made over 2 trades of the Omnicell stock since 2021, according to the Form 4 filled with the SEC. Most recently she sold 7,951 units of OMCL stock worth $581,536 on 9 June 2023.
The largest trade she's ever made was selling 7,951 units of Omnicell stock on 9 June 2023 worth over $581,536. On average, Ms trades about 888 units every 85 days since 2021. As of 9 June 2023 she still owns at least 14,876 units of Omnicell stock.
You can see the complete history of Ms Mellon stock trades at the bottom of the page.
Christine Mellon is the Exec. VP, Chief Admin. & People Officer at Omnicell.
As the Exec. VP i Chief Admin. & People Officer of Omnicell, the total compensation of Ms Mellon at Omnicell is $768,277. There are 8 executives at Omnicell getting paid more, with Randall Lipps having the highest compensation of $7,208,970.
Ms Mellon is 58, she's been the Exec. VP i Chief Admin. & People Officer of Omnicell since . There are 13 older and 6 younger executives at Omnicell. The oldest executive at Omnicell, Inc. is Sara White, 74, who is the Independent Director.
Over the last 21 years, insiders at Omnicell have traded over $118,258,750 worth of Omnicell stock and bought 526,030 units worth $5,215,749 . The most active insiders traders include William H Jr Younger, Randall A Lipps oraz Benjamin A Horowitz. On average, Omnicell executives and independent directors trade stock every 10 days with the average trade being worth of $482,255. The most recent stock trade was executed by Christine Marie Mellon on 9 June 2023, trading 7,951 units of OMCL stock currently worth $581,536.
since 1992, omnicell has been creating new efficiencies to improve patient care, anywhere it is delivered. omnicell is a leading supplier of comprehensive automation and business analytics software for patient-centric medication and supply management across the entire health care continuum—from the acute care hospital setting to post-acute skilled nursing and long-term care facilities to the home. omnicell’s automated hardware/software systems for medication dispensing include solutions from the point of entry into the hospital through the central pharmacy, nursing unit, operating room, and patient bedside. our supply management systems promote greater cost control and charge capture for payer reimbursement, and improve management and reordering of inventory. omnicell® products range from high-security, closed-cabinet systems and software to open-shelf and combination systems in the nursing unit, cath lab, and operating room. more than 3,200 customers worldwide have utilized omnice
Omnicell executives and other stock owners filed with the SEC include: